Latest data from May 6, 2022
Number of Health Center respondents = 31 (84% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 8,023 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 76.42% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 914 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 69.97% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 20.70% | 26.15% |
White, Hispanic/Latino Patients | 28.56% | 20.02% |
Black/African American, Non-Hispanic/Latino Patients | 12.88% | 16.52% |
Black/African American, Hispanic/Latino Patients | 5.95% | 6.02% |
Asian Patients3 | 4.51% | 6.35% |
American Indian/Alaska Native Patients3 | 0.44% | 0.44% |
Native Hawaiian/Other Pacific Islander Patients3 | 1.05% | 0.44% |
Patients with More Than One Race3 | 3.25% | 2.41% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 10.46% | 8.75% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.20% | 5.80% |
Unreported/Refused to Report Race and Ethnicity | 7.02% | 7.11% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 847 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 73.23% |
COVID-19 Immunization Series Completed | 803 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 81.72% |
COVID-19 Immunization Series Additional | 2,676 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 64.51% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 22.79% | 16.19% | 32.96% |
White, Hispanic/Latino Patients | 17.59% | 23.16% | 13.34% |
Black/African American, Non-Hispanic/Latino Patients | 18.18% | 21.79% | 19.77% |
Black/African American, Hispanic/Latino Patients | 5.31% | 5.35% | 7.17% |
Asian Patients3 | 3.42% | 3.61% | 7.70% |
American Indian/Alaska Native Patients3 | 0.24% | 0.00% | 1.12% |
Native Hawaiian/Other Pacific Islander Patients3 | 1.30% | 1.00% | 0.90% |
Patients with More Than One Race3 | 5.79% | 6.48% | 4.41% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 10.51% | 10.96% | 5.49% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.55% | 4.61% | 2.39% |
Unreported/Refused to Report Race and Ethnicity | 9.33% | 6.85% | 4.75% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 6.45% |
1 to 24 Hours | 38.71% |
More Than 24 Hours | 45.16% |
N/A | 9.68% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 6.45% |
Staffing to administer the vaccine | 22.58% |
Vaccine confidence | 35.48% |
Vaccine storage capacity | 3.23% |
Vaccine supply | 6.45% |
Other | 9.68% |
None | 35.48% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 16.13% |
Average Percent of Health Center Visits Conducted Virtually | 21.94% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 32.26% |
Number of Mobile Van Sites | 21 |
Number of Pop-up Clinics | 5 |
Number of School-Based Vaccination Sites | 13 |
Number of Family Vaccination Clinics | 14 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 6.45% |
Refer patients to another organization that provides monoclonal antibody therapies | 51.61% |
None | 41.94% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 16.13% |
Patient awareness/education | 3.23% |
Staffing capacity | 12.90% |
Therapy administration/onsite logistics | 9.68% |
Other | 9.68% |
None | 58.06% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 17 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 8,718 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 88.24% |
Provided to General Public Who Came to the Health Center | 58.82% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 23.53% |
Provided at Other Community Events | 47.06% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 5.88% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 35.29% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 35.29% |
Provided to school-age children and/or their families directly or through partnerships with schools | 29.41% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 29.41% |
Other | 11.76% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 9 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 3,973 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 100.00% |
Provided to General Public Who Came to the Health Center | 66.67% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 33.33% |
Provided at Other Community Events | 66.67% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 11.11% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 44.44% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 44.44% |
Provided to school-age children and/or their families directly or through partnerships with schools | 22.22% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 14 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 47.27% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 38.18% |
White, Hispanic/Latino Patients | 15.45% |
Black/African American, Non-Hispanic/Latino Patients | 7.73% |
Black/African American, Hispanic/Latino Patients | 1.82% |
Asian Patients3 | 2.27% |
American Indian/Alaska Native Patients3 | 0.91% |
Native Hawaiian/Other Pacific Islander Patients3 | 3.18% |
Patients with More Than One Race3 | 1.82% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 14.09% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 10.00% |
Unreported/Refused to Report Race and Ethnicity | 4.55% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 0.00% |
Patients Experiencing Homelessness | 0.91% |
Patients Who Are Residents of Public Housing | 11.82% |
Patients with Limited English Proficiency | 30.00% |
Children Under 18 Years of Age | 1.82% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.